Capricor Therapeutics (CAPR) Other Working Capital Changes (2010 - 2026)
Capricor Therapeutics (CAPR) posted quarterly Other Working Capital Changes of -$1.1 million for Q4 2024, up 45.86% year-over-year from -$775068.9 in Q1 2024, and up 50.01% quarter-over-quarter from -$2.3 million in Q3 2024.
Powered by 
Analysis
Capricor Therapeutics (CAPR) Other Working Capital Changes (2010 - 2026) Analysis & Trends
Capricor Therapeutics' Other Working Capital Changes history runs 5 years deep, the most recent figure standing at -$1.1 million for Q4 2024.
- In Q4 2024, Other Working Capital Changes rose 45.86% year-over-year to -$1.1 million; the TTM figure through Dec 2024 stood at -$12.3 million (down 286.1% YoY), while the FY2024 annual figure was -$12.3 million, down 286.1% from the prior year.
- Other Working Capital Changes for Q4 2024 stood at -$1.1 million, up from -$2.3 million in the prior quarter.
- The five-year high for Other Working Capital Changes was $3.3 million in Q4 2025, with the low at -$979776.0 in Q1 2026.
- The 5-year median for Other Working Capital Changes is -$125418.0 (2023), against an average of $200491.1.
- The sharpest annual moves came in 2023 and 2024: Other Working Capital Changes tumbled 288.66% in 2023, then soared 63.44% in 2024.
- Capricor Therapeutics' Other Working Capital Changes stood at -$959903.0 in 2022, then sank by 117.53% to -$2.1 million in 2023, then jumped by 45.86% to -$1.1 million in 2024.
- Business Quant data shows CAPR's Other Working Capital Changes at -$1.1 million in Q4 2024, -$2.3 million in Q3 2024, and -$4.0 million in Q2 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Capricor Therapeutics | 543.30 Mn | 543.30 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -81,827.00 |
| Jun 30, 2026 | -81,827.00 |
| Mar 31, 2026 | -979,776.00 |
| Mar 31, 2026 | -979,776.00 |
| Dec 31, 2025 | 3.33 Mn |
| Dec 31, 2025 | 3.33 Mn |
| Sep 30, 2025 | 966,329.00 |
| Sep 30, 2025 | 966,329.00 |
| Jun 30, 2025 | -142,770.00 |
| Jun 30, 2025 | -142,770.00 |
| Mar 31, 2025 | -55,473.00 |
| Mar 31, 2025 | -55,473.00 |
| Dec 31, 2024 | 1.02 Mn |
| Dec 31, 2024 | 1.02 Mn |
| Sep 30, 2024 | -452,465.00 |
| Sep 30, 2024 | -452,465.00 |
| Jun 30, 2024 | -237,240.00 |
| Jun 30, 2024 | -237,240.00 |
| Mar 31, 2024 | 130,068.00 |
| Mar 31, 2024 | 130,068.00 |